These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25134407)

  • 21. Sunshine Act: 7 things you need to know.
    Treumann JE
    Med Econ; 2013 Mar; 90(6):64, 66-9. PubMed ID: 24066449
    [No Abstract]   [Full Text] [Related]  

  • 22. [Physicians and the drug industry. "To be like that, you'd better be married."].
    Peiró S
    Rev Calid Asist; 2009 Apr; 24(2):47-50. PubMed ID: 19426926
    [No Abstract]   [Full Text] [Related]  

  • 23. A higher bar--Vermont's new law on marketing prescribed products.
    Steinbrook R
    N Engl J Med; 2009 Jul; 361(1):8-9. PubMed ID: 19516028
    [No Abstract]   [Full Text] [Related]  

  • 24. Key opinion leaders and the corruption of medical knowledge: what the Sunshine Act will and won't cast light on.
    Sismondo S
    J Law Med Ethics; 2013; 41(3):635-43. PubMed ID: 24088154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disclosure of industry payments to physicians.
    Steinbrook R
    N Engl J Med; 2008 Aug; 359(6):559-61. PubMed ID: 18687636
    [No Abstract]   [Full Text] [Related]  

  • 26. Plan to force drug companies in France to reveal payments to doctors has been diluted, campaigners say.
    Benkimoun P
    BMJ; 2012 Dec; 345():e8405. PubMed ID: 23236045
    [No Abstract]   [Full Text] [Related]  

  • 27. GMC says it can't force doctors to disclose payments from drug companies.
    Torjesen I
    BMJ; 2016 Jul; 354():i3806. PubMed ID: 27390102
    [No Abstract]   [Full Text] [Related]  

  • 28. Doctors face compulsory system to declare gifts and hospitality from drug companies.
    O'Dowd A
    BMJ; 2015 Aug; 351():h4617. PubMed ID: 26311722
    [No Abstract]   [Full Text] [Related]  

  • 29. French "sunshine act" sheds little light on drug industry's payments to doctors, say critics.
    Benkimoun P
    BMJ; 2013 Jun; 346():f3762. PubMed ID: 23757751
    [No Abstract]   [Full Text] [Related]  

  • 30. [Conflict of interest regarding clinical physicians' relationship with pharmaceutical industry and medical education].
    Miyata Y
    Seishin Shinkeigaku Zasshi; 2010; 112(11):1136-45. PubMed ID: 21226250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Letting the sunshine in: shining a new light on physician-industry relationships.
    Bruguera CM; Hirsch JA
    J Neurointerv Surg; 2010 Mar; 2(1):80-2. PubMed ID: 21990565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmaceutical industry and the medical profession.
    Phatak A
    Issues Med Ethics; 1998; 6(4):131-2. PubMed ID: 16267942
    [No Abstract]   [Full Text] [Related]  

  • 33. Health policy basics: the Physician Payment Sunshine Act and the Open Payments program.
    Kirschner NM; Sulmasy LS; Kesselheim AS
    Ann Intern Med; 2014 Oct; 161(7):519-21. PubMed ID: 25069795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transparency lacking. Despite Sunshine Act rules, policies still an issue.
    Lee J
    Mod Healthc; 2013 Mar; 43(10):10-1. PubMed ID: 23593894
    [No Abstract]   [Full Text] [Related]  

  • 35. Defusing a time bomb.
    Nat Biotechnol; 2008 Oct; 26(10):1051. PubMed ID: 18846052
    [No Abstract]   [Full Text] [Related]  

  • 36. New US law applies 'sunshine' to physician payments and gifts from drug, device industries.
    Woodward C
    CMAJ; 2010 Jul; 182(10):E467-8. PubMed ID: 20501787
    [No Abstract]   [Full Text] [Related]  

  • 37. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

  • 38. An Analysis of the Open Payment Database in Neurotology.
    Ziai K; Sahyouni R; Moshtaghi O; Vu K; Goshtasbi K; Ghavami Y; Lee L; Lin HW; Djalilian HR
    Otolaryngol Head Neck Surg; 2018 Feb; 158(2):319-322. PubMed ID: 29389305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transparency urged over research payments.
    Check E
    Nature; 2007 Aug; 448(7155):738. PubMed ID: 17700667
    [No Abstract]   [Full Text] [Related]  

  • 40. Let the sunshine in--making industry payments to New Zealand doctors transparent.
    Farquhar C; Stokes T; Grey A; Jeffery M; Griffin P
    N Z Med J; 2015 Mar; 128(1411):6-12. PubMed ID: 25820497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.